ResearchAntibody Responses to SARS-CoV-2 Vaccine in Nursing Home Residents Support a Bi-Annual Update Schedule
ResearchDurability of Clinical Protection in Nursing Home Residents Following Monovalent KP.2 SARS-CoV-2 Vaccination
May 28, 2026Journal ArticleRespiratory surveillance through point of care molecular testing and its impacts on nursing home RSV, influenza, and SARS-CoV-2 awareness and reporting behavior: a pilot study.Written by 2 Roon authors & 10 others Via Antimicrobial Stewardship & Healthcare Epidemiology
ResearchDementia Risk After Recombinant Herpes Zoster Vaccination in Older Adults With a Recent Skilled-Nursing Facility Stay: A Target Trial Emulation
ResearchVaccine Effectiveness of mRNA-1345 Against RSV-Associated Hospitalization and Medically Attended Acute Respiratory Illness Among US Veterans, 2025–2026
ResearchComparative Immunogenicity of mRNA-1273 and BNT162b2 SARS-CoV-2 Bivalent Booster Vaccines in US Nursing Home Residents
ResearchRecombinant vs Egg-Based Quadrivalent Influenza Vaccination for Nursing Home Residents: A Cluster Randomized Trial
ResearchCOVID-19 Booster Doses Reduce Sex Disparities in Antibody Responses Among Nursing Home Residents
ResearchOutcomes of Human Metapneumovirus Infections in Nursing Home Residents: A Matched Cohort Analysis
ResearchA Simultaneous Mixed-Methods Examination of Factors Influencing Intent-to-Leave Among Nursing Home Care Providers in 25 Long-Term Care Facilities
ResearchImmunologic Evaluation of First and Second Doses of SARS-CoV-2 XBB.1.5 and the KP.2 Monovalent Booster Vaccines in Nursing Home Residents
ResearchAvidity Maturation of Humoral Response Following Primary and Booster Doses of BNT162b2 mRNA Vaccine Among Nursing Home Residents and Healthcare Workers